COVID-19 and pregnancy: A European study on pre- and post-infection medication use.
Eimir HurleyBenjamin P GeislerAngela LupattelliBeatriz Poblador-PlouRégis LassalleJérémy JovéMarie-Agnes BernardDunia SakrGabriel Sanfélix-GimenoFrancisco Sanchez-SaezClara L Rodríguez-BernalMònica SabatéElena BallarínCristina AguileraSusan JordanDaniel ThayerIan FarrSaira AhmedClaudia BartoliniGiorgio LimoncellaOlga PaolettiRosa GiniLuigi A MaglanocElena DudukinaVera EhrensteinEma AlsinaTiago Andres VazJudit Riera-ArnauMiriam C J M SturkenboomHedvig Marie Egeland NordengPublished in: European journal of clinical pharmacology (2024)
Our findings highlight the substantial impact of COVID-19 on primary care medication use among pregnant women, with a marked increase in the use of antithrombotic medications post-COVID-19. These results underscore the need for further research to understand the broader implications of these patterns on maternal and neonatal/fetal health outcomes.